BEVERLY HILLS, CA--(Marketwired - Jul 27, 2015) - mCig, Inc. (
mCig's flexible loan programs are designed for businesses that have been turned down for conventional bank loans due to banks' refusal to loan to cannabis companies and ensures investment capital is quickly and affordably available with minimal paperwork and no asset collateral. mCig has partnered with a third-party lender with expertise in sub-prime debt lending, eliminating any risk to mCig. Loan caps at $150,000 per signature, but there is no limit to signatures per business and are structured similar to a credit card to help finance equipment and most startup needs for entrepreneurs in the cannabis industry.
"It was clear that our customers needed capital to grow, so we partnered to fill a missing component that will complement our existing offerings and make it easier to close a sale," said Paul Rosenberg, CEO of mCig. "As an example, our grower services can now complete a full singular turnkey package to provide financing for the CannaPod growing structure, the actual grow equipment that goes inside, a security system, an extraction machine, and even the consulting to efficiently run that singular grow package."
As mCig completes its corporate restructuring, this final piece of financing enhances the Company's vision to service growers and dispensaries, both of which share the needs of security, consultative services and financing.
For more information on mCig's Financing Services or to apply for a loan, please visit www.mcig.org/financing
About mCig, Inc.
mCig, Inc. (
Safe Harbor Statement
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Any forward-looking statements contained herein are based on current expectations, but are subject to a number of risks and uncertainties. The factors that could cause actual future results to differ materially from current expectations include, but are not limited to, risks and uncertainties relating to the Company's ability to develop, market and sell products based on its technology; the expected benefits and efficacy of the Company's products and technology; the availability of substantial additional funding for the Company to continue its operations and to conduct research and development, and future product commercialization; and the Company's business, research, product development, regulatory approval, marketing and distribution plans and strategies.
Contact Information:
Contact:
mCig Inc.
pr@mcig.org